Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
somatropin (protropin) (4 trials)
interferon beta-1b (betaseron) (2 trials)
Dwarfism, Pituitary (Phase 3)
Endocrine System Diseases (Phase 3)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 1)
Pituitary Diseases (Phase 3)
Trials (6 total)
Trial APIs (2 total)